Background
==========

Elevated levels of B-type natriuretic peptide (BNP) drawn at presentation and concomitant cardiac troponin I (cTnI) after coronary heart disease associated with electrocardiographic alterations for high mortality. Sparse data are available on its use at first presentation with non-ST-segment elevation myocardial infarction (NSTEMI).

Objectives
==========

We sought to evaluate BNP, alone and in comparison with cTnI and electrocardiography alterations, for risk assessment at initial presentation NSTEMI.

Methods
=======

We obtained samples from 50 patients presenting within 6 hours of NSTEMI admission to our coronary unit care with electrocardiography alterations, and measured BNP/troponin I at 0 hours and 6--12 hours after admission. All patients underwent coronary angiography for treatment of NSTEMI.

Results
=======

Of 50 patients, 42 were men. The mean age was 67.3 years. The median BNP was higher in patients who died (89 pg/ml, 25th--75th percentile: 40--192), compared with survivors (15 pg/ml, 25th--75th percentile: 8.8--32, *P*\< 0.0001). Patients with BNP \>80 pg/ml were at significantly higher risk of death (17.4% vs 1.8%, *P*\< 0.0001). Cardiac troponin established a gradient of mortality between the highest and lowest quartile (7.9% vs 0%, *P*= 0.007). Patients with BNP \>80 pg/ml were also more likely to have impaired coronary flow (*P*= 0.049) and more electrocardiography alterations of the ST segment (*P*= 0.05).

Conclusions
===========

Increased concentrations of BNP at initial presentation of patients with NSTEMI are associated with electrocardiography alterations and cTnI impaired reperfusion after coronary angiography and higher short-term risk of mortality. These data support the value of combining markers of hemodynamic stress with traditional approaches to risk assessment in non-ST elevation of myocardial infarction.
